- Home
- ATCH vs ICCM Comparison
ATCH vs ICCM Comparison
Compare ATCH & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | ATCH | ICCM |
|---|---|---|
| Founded | 2022 | 2006 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.2M | 45.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ATCH | ICCM |
|---|---|---|
| Price | $0.25 | $0.61 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | ★ 4.2M | 428.1K |
| Earning Date | 02-18-2026 | 11-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,303,120.00 | $2,975,000.00 |
| Revenue This Year | N/A | $13.67 |
| Revenue Next Year | N/A | $38.55 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 80.78 | N/A |
| 52 Week Low | $0.14 | $0.58 |
| 52 Week High | $15.27 | $1.66 |
Technical Indicators
Market Signals| Indicator | ATCH | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 34.35 | 35.67 |
| Support Level | $0.25 | $0.65 |
| Resistance Level | $0.27 | $0.68 |
| Average True Range (ATR) | 0.02 | 0.03 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 0.89 | 23.29 |
Price Performance
Historical ComparisonAbout ATCH AtlasClear Holdings Inc.
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.